Type 2 & other diabetes

Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiometabolic multimorbidity in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a prospective cohort study

Cardiovasc DiabetolPublished Prospective cohort study

Authors' conclusion

Among individuals with CKM syndrome stages 0-3, AIP-related indices were positively associated with the incidence and progression of CMM, supporting their potential utility for CMM risk stratification within the CKM framework. These indices, particularly AIP-BRI, may provide additional predictive information. Exploratory biomarker findings might provide preliminary clues for future mechanistic research.

Study context

Population
UK Biobank participants with cardiovascular-kidney-metabolic (CKM) syndrome stages 0–3 without baseline T2D, coronary heart disease or stroke
Participants
346,868 participants
Exposure
Per 1-SD increment in atherogenic index of plasma (AIP)-related indices
Outcome
Incident cardiometabolic multimorbidity (CMM): coexistence of at least two of T2D, coronary heart disease, stroke
Follow-up
Median 15.9 years
Methodological detailsUK Biobank
  • UK Biobank

Main finding

As reported in the abstract

Incident CMM

Participants developing cardiometabolic multimorbidity (CMM)

8573

All eight AIP-related indices positively associated with incident CMM; HR per 1-SD increment (all P < 0.001)

1.12 to 1.37

Observational data: associations, not effects.

Further findings

CMM progression (multistate models)

Stage-specific associations; stronger for transition from baseline to T2D and from single CMD to CMM involving coronary heart disease (CHD) (all P < 0.001)

Incremental predictive value

Adding each index to conventional risk factors improved discrimination and reclassification; AIP-body roundness index (AIP-BRI) showed the greatest overall incremental predictive value

Exploratory biomarker analyses

Inflammatory, liver and renal biomarkers jointly accounted for share of associations
32.5-46.4%
  • Should not be interpreted as evidence of causal mediation

Original publication

Associations of the atherogenic index of plasma and its modified indices with the incidence and progression of cardiometabolic multimorbidity in individuals with cardiovascular-kidney-metabolic syndrome stages 0–3: a prospective cohort study. Cardiovasc Diabetol. Published 14 June 2026. doi:10.1186/s12933-026-03255-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.